Dermata Therapeutics, Inc. Announces Closing of Upsized $18.0 Million Initial Public Offering

SAN DIEGO, CA / ACCESSWIRE / August 17, 2021 / Dermata Therapeutics, Inc. ("Dermata" or the "Company") (NASDAQ:DRMA, DRMAW), a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases and conditions, today announced the closing of its previously announced initial public offering of 2,571,428 shares of its common stock and accompanying warrants to purchase

from Yahoo Canada Sports - Sports News, Scores, Rumours, Fantasy Games, and more https://ift.tt/37TNU4N
via IFTTT